PL1732902T3 - Pochodne nukleozydów i ich terapeutyczne zastosowanie - Google Patents
Pochodne nukleozydów i ich terapeutyczne zastosowanieInfo
- Publication number
- PL1732902T3 PL1732902T3 PL05733004T PL05733004T PL1732902T3 PL 1732902 T3 PL1732902 T3 PL 1732902T3 PL 05733004 T PL05733004 T PL 05733004T PL 05733004 T PL05733004 T PL 05733004T PL 1732902 T3 PL1732902 T3 PL 1732902T3
- Authority
- PL
- Poland
- Prior art keywords
- nucleoside derivatives
- therapeutic use
- compounds
- methods
- administering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55814104P | 2004-04-01 | 2004-04-01 | |
| PCT/US2005/011313 WO2005097757A2 (en) | 2004-04-01 | 2005-04-01 | Nucleoside derivatives and therapeutic use thereof |
| EP05733004A EP1732902B1 (en) | 2004-04-01 | 2005-04-01 | Nucleoside derivatives and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1732902T3 true PL1732902T3 (pl) | 2010-06-30 |
Family
ID=34979006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05733004T PL1732902T3 (pl) | 2004-04-01 | 2005-04-01 | Pochodne nukleozydów i ich terapeutyczne zastosowanie |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7405214B2 (pl) |
| EP (1) | EP1732902B1 (pl) |
| JP (2) | JP5001832B2 (pl) |
| KR (1) | KR100926596B1 (pl) |
| CN (2) | CN102091072A (pl) |
| AT (1) | ATE453628T1 (pl) |
| AU (1) | AU2005230676B2 (pl) |
| BR (1) | BRPI0509553B8 (pl) |
| CA (1) | CA2562965C (pl) |
| DE (1) | DE602005018620D1 (pl) |
| ES (1) | ES2334803T3 (pl) |
| IN (1) | IN2014DN04587A (pl) |
| MX (1) | MXPA06011141A (pl) |
| PL (1) | PL1732902T3 (pl) |
| WO (1) | WO2005097757A2 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9315534B2 (en) * | 2007-08-10 | 2016-04-19 | Board Of Regents Of The University Of Nebraska | Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents |
| US20120269725A1 (en) * | 2009-12-23 | 2012-10-25 | Janine Baranowska-Kortylewicz | Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer |
| ES2678085T3 (es) * | 2013-03-15 | 2018-08-08 | Rexahn Pharmaceuticals, Inc. | Proceso para la preparación de 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1H-pirimidin-2-ona |
| ES2903212T3 (es) | 2015-06-09 | 2022-03-31 | Ocuphire Pharma Inc | Usos y procedimientos de preparación de fluorociclopentenilcitosina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6187674A (ja) * | 1984-10-06 | 1986-05-06 | Yoshitomi Pharmaceut Ind Ltd | シクロペンテン環を有する新規ヌクレオシド |
| US4975434A (en) * | 1986-05-27 | 1990-12-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antiviral and anticancer cyclopentenyl cytosine |
| CN1646141B (zh) * | 2000-10-18 | 2014-06-25 | 吉利德制药有限责任公司 | 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 |
| TWI299664B (en) * | 2003-01-06 | 2008-08-11 | Osi Pharm Inc | (2-carboxamido)(3-amino)thiophene compounds |
-
2005
- 2005-04-01 KR KR1020067022856A patent/KR100926596B1/ko active IP Right Grant
- 2005-04-01 CN CN2010105546004A patent/CN102091072A/zh active Pending
- 2005-04-01 AT AT05733004T patent/ATE453628T1/de not_active IP Right Cessation
- 2005-04-01 CA CA2562965A patent/CA2562965C/en active Active
- 2005-04-01 AU AU2005230676A patent/AU2005230676B2/en active Active
- 2005-04-01 JP JP2007506347A patent/JP5001832B2/ja active Active
- 2005-04-01 US US11/095,686 patent/US7405214B2/en active Active
- 2005-04-01 WO PCT/US2005/011313 patent/WO2005097757A2/en active Application Filing
- 2005-04-01 CN CN2005800178253A patent/CN1980898B/zh active Active
- 2005-04-01 EP EP05733004A patent/EP1732902B1/en active Active
- 2005-04-01 BR BRPI0509553A patent/BRPI0509553B8/pt active IP Right Grant
- 2005-04-01 IN IN4587DEN2014 patent/IN2014DN04587A/en unknown
- 2005-04-01 ES ES05733004T patent/ES2334803T3/es active Active
- 2005-04-01 MX MXPA06011141A patent/MXPA06011141A/es active IP Right Grant
- 2005-04-01 PL PL05733004T patent/PL1732902T3/pl unknown
- 2005-04-01 DE DE602005018620T patent/DE602005018620D1/de active Active
-
2012
- 2012-03-12 JP JP2012054597A patent/JP2012107072A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1732902A2 (en) | 2006-12-20 |
| ES2334803T3 (es) | 2010-03-16 |
| ATE453628T1 (de) | 2010-01-15 |
| MXPA06011141A (es) | 2007-08-14 |
| AU2005230676B2 (en) | 2010-10-07 |
| BRPI0509553A (pt) | 2007-09-18 |
| JP2007531736A (ja) | 2007-11-08 |
| EP1732902B1 (en) | 2009-12-30 |
| US7405214B2 (en) | 2008-07-29 |
| WO2005097757A3 (en) | 2005-12-08 |
| JP2012107072A (ja) | 2012-06-07 |
| KR20070012685A (ko) | 2007-01-26 |
| CA2562965C (en) | 2013-10-29 |
| CA2562965A1 (en) | 2005-10-20 |
| BRPI0509553B1 (pt) | 2019-06-18 |
| US20050222185A1 (en) | 2005-10-06 |
| CN1980898A (zh) | 2007-06-13 |
| KR100926596B1 (ko) | 2009-11-11 |
| IN2014DN04587A (pl) | 2015-07-10 |
| CN102091072A (zh) | 2011-06-15 |
| CN1980898B (zh) | 2011-01-12 |
| JP5001832B2 (ja) | 2012-08-15 |
| WO2005097757A2 (en) | 2005-10-20 |
| AU2005230676A1 (en) | 2005-10-20 |
| DE602005018620D1 (de) | 2010-02-11 |
| BRPI0509553B8 (pt) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
| MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
| TW200612936A (en) | Indole derivatives | |
| RS20080533A (en) | Triazolopyrazine derivatives useful as anticancer agents | |
| EA200800665A1 (ru) | АГЕНТЫ ДЛЯ ПРЕДУПРЕЖДЕНИЯ И ЛЕЧЕНИЯ НАРУШЕНИЙ, ВКЛЮЧАЮЩИХ МОДУЛИРОВАНИЯ RyR РЕЦЕПТОРОВ | |
| DE602006014579D1 (de) | Heteroalkylgebundene pyrimidinderivate | |
| ATE430744T1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
| TW200626158A (en) | Naphthaline derivatives | |
| HK1095138A1 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| NO20080475L (no) | Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators | |
| TW200600506A (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
| MX2010013682A (es) | Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos. | |
| MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
| TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
| TW200800946A (en) | Substituted piperazines as metabotropic glutamate receptor antagonists | |
| TW200637817A (en) | 5-aminoindole derivatives | |
| IL191763A0 (en) | Pyrrolo [2,3-b]pyridine derivatives as h3 receptor modulators | |
| IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
| TW200639156A (en) | New compounds | |
| UA92009C2 (ru) | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия | |
| MX2008012093A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos. | |
| UA86873C2 (en) | SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES | |
| MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
| NO20080671L (no) | Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister |